APA (7th ed.) Citation

Abusaif, M. S., Sh El-Sharief, A. M., Mohamed, Y. A., Ammar, Y. A., Ismail, M. A., Aboulthana, W. M., . . . Ragab, A. (2025). Exploring novel of 1,2,4-triazolo[4,3-a]quinoxaline sulfonamide regioisomers as anti-diabetic and anti-Alzheimer agents with in-silico molecular docking simulation. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-03139-9

Chicago Style (17th ed.) Citation

Abusaif, Moustafa S., Ahmed M. Sh El-Sharief, Yehia A. Mohamed, Yousry A. Ammar, Mostafa A. Ismail, Wael M. Aboulthana, Mohamed S. A. El-Gaby, and Ahmed Ragab. "Exploring Novel of 1,2,4-triazolo[4,3-a]quinoxaline Sulfonamide Regioisomers as Anti-diabetic and Anti-Alzheimer Agents with In-silico Molecular Docking Simulation." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-03139-9.

MLA (9th ed.) Citation

Abusaif, Moustafa S., et al. "Exploring Novel of 1,2,4-triazolo[4,3-a]quinoxaline Sulfonamide Regioisomers as Anti-diabetic and Anti-Alzheimer Agents with In-silico Molecular Docking Simulation." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-03139-9.